FDA Approves Symbravo for Acute Treatment of Migraine in Adults
Symbravo can rapidly eliminate migraine pain within two hours, with efficacy sustained through 24 and 48 hours, across migraine pain severity ...
FDA Approves Susvimo for Diabetic Macular Edema
Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with fewer treatments based on its continuous delivery of a customized formulation ...
Alpha Tau announces FDA approval of IDE supplement
Medical announced an approval from the U.S. Food and Drug Administration, FDA, of an Investigational Device Exemption IDE, ...
Watch: RFK ‘sneakily uses nicotine pouch during Senate hearing’
Social media posters speculate that Donald Trump’s pick for US health secretary could have been using Zyn product ...
5 things to know for Jan. 31: Plane collision, Confirmation hearings, Pain medicine, Japan sinkhole, FireAid benefit concerts
While America retains a gold standard for airline safety, there are stresses on the US air travel system that have been ...
Alaska Dispatch News6d
FDA approves new painkiller aimed at eliminating risks of addiction associated with opioids
WASHINGTON — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and ...
The Canadian Press on MSN6d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Axsome Therapeutics announces FDA approval of Symbravo
Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in ...